事前指示書市場 : 2028年までの世界予測

Report Overview

The advance directives market is projected to reach USD 291.1 billion by 2028 from USD 122.9 billion in 2023, at a CAGR of 18.8% during the forecast period. The rising inestments in advance directives and government initiatives and regulations to enhance patient care and autonomy will provide lucrative opportunities to the market during the forecast period.

“Advance directives services segment accounted for a substantial share of the advance directives market, by component in 2022.”
In 2022, the advance directives services segment accounted for a substantial share of the advance directives market. Rising awareness of the importance of proactive healthcare planning, healthcare policies and regulations are increasingly recognizing the benefits of advance directives in terms of reducing unwanted interventions, healthcare costs, and ensuring patient-centered care. This recognition has led healthcare systems to integrate these services into their standard practices, driving the segment’s rapid growth.

“Healthcare Providers segment accounted for a considerable share in the advance directives market, by end user in 2022”
In 2022, the healthcare providers segment accounted for a significant share of the advance directives market. As healthcare systems prioritize patient-centered care and personalized treatment, providers play a key role in initiating conversations about end-of-life preferences, treatment options, and medical interventions. Their expertise and trusted relationships with patients position them to effectively navigate sensitive discussions surrounding advance care planning. Moreover, healthcare providers’ adoption of electronic health records (EHRs) and digital tools has streamlined the documentation and dissemination of AD documents, enhancing the accessibility and implementation of patient wishes. As a result, the healthcare providers segment stands as a prominent driver of growth within the advance directives market.

“Asia to witness the substantial growth rate during the forecast period.”
The Asian market is projected to grow at the high CAGR during the forecast period due to a confluence of factors that reflect evolving societal attitudes, increased healthcare access, and a growing awareness of patient autonomy. As the region undergoes demographic shifts, including an aging population and an increase in chronic diseases, there is a heightened recognition of the importance of end-of-life planning. Governments and healthcare organizations are working to overcome cultural taboos surrounding discussions of death and end-of-life care, fostering a more open dialogue. Additionally, advancements in healthcare infrastructure and a rise in patient-centered care initiatives are facilitating greater access to AD resources. The desire for patients to have a say in their medical decisions, coupled with efforts to align medical care with individual preferences, is propelling the substantial growth of AD in Asia’s forecasted years.

The break-down of primary participants is as mentioned below:
• By Company Type – Tier 1: 45%, Tier 2: 30%, and Tier 3: 25%
• By Designation – C-level: 42%, Director-level: 31%, and Others: 27%
• By Region – North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

Key Players in the Advance directives  Solutions Market
The key players operating in the advance directives market include ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US), Bronson Health Care Group, Inc. (US), Koda Health(US), ThroughCare, Inc.(US), Vital Decisions LLC (US), Affirm Health Inc. (US), MIDEO(US), New Century Health (US), Thanacare(US), Island Health(Canada), Honor My Decisions LLC (US).
Research Coverage:
The report analyzes the Advance directives Market and aims to estimate the market size and future growth potential of various market segments, based on components, demographics , end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.
Reasons to Buy the Report
This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.
This report provides insights on:
n Analysis of key drivers (increasing Investments in advance directives in developed as well as emerging technology adoption, rising demand for personalized care, increasing funding and investments in advance care planning, restraints (lack of awareness and education, communication barrier, opportunities (technological advancement and digital solutions, policy support and legislative framework), and challenges (fragmented healthcare system and lack of indiciplinary collaboration and commiunication) influencing the growth of the advance directives market.
n Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the advance directives market.
n Market Development: Comprehensive information on the lucrative emerging markets, component, demographics , end-user, and region.
n Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the advance directives market
n Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the advance directives market like ADvault, Inc.(US), VyncaCare (US), WiserCare Inc.(US), Sharp HealthCare(US), ACP Decisions (a DBA of Nous Foundation, Inc.) (US), Iris Healthcare(Aledade, Inc.) (US) etc.

Table of Contents

1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.2.1 INCLUSIONS AND EXCLUSIONS 22
1.3 MARKET SCOPE 23
1.3.1 MARKETS COVERED 23
FIGURE 1 ADVANCE CARE PLANNING SOLUTIONS MARKET SEGMENTATION 23
1.3.2 YEARS CONSIDERED 23
1.3.3 CURRENCY CONSIDERED 24
1.4 STAKEHOLDERS 24
1.5 LIMITATIONS 24
1.6 RECESSION IMPACT 24
2 RESEARCH METHODOLOGY 25
2.1 RESEARCH DATA 25
FIGURE 2 RESEARCH DESIGN 25
2.1.1 SECONDARY DATA 26
2.1.1.1 Key data from secondary sources 26
2.1.2 PRIMARY DATA 27
FIGURE 3 PRIMARY SOURCES 27
2.1.2.1 Key data from primary sources 28
2.1.2.2 Insights from primary experts 29
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 29
2.2 MARKET SIZE ESTIMATION 30
2.2.1 APPROACH 1: BOTTOM-UP APPROACH (DEMAND-SIDE ANALYSIS) 30
FIGURE 5 BOTTOM-UP APPROACH (DEMAND SIDE ANALYSIS) 30
2.2.2 APPROACH 2: TOP-DOWN OF PARENT MARKET ASSESSMENT 31
2.2.3 APPROACH 3: PRIMARY INTERVIEWS 31
2.2.4 APPROACH 4: TOP-DOWN APPROACH 31
FIGURE 6 TOP-DOWN APPROACH 31
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, OPPORTUNITIES, AND CHALLENGES 32
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 33
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 34
FIGURE 9 DATA TRIANGULATION METHODOLOGY 34
2.4 MARKET SHARE ESTIMATION 35
2.5 STUDY ASSUMPTIONS 35
2.6 RESEARCH LIMITATIONS 35
2.6.1 METHODOLOGY-RELATED LIMITATIONS 35
2.7 RISK ASSESSMENT 36
TABLE 1 RISK ASSESSMENT: ADVANCE CARE PLANNING SOLUTIONS MARKET 36
2.8 ADVANCE CARE PLANNING SOLUTIONS MARKET: RECESSION IMPACT ANALYSIS 36
3 EXECUTIVE SUMMARY 37
FIGURE 10 ADVANCE CARE PLANNING SOLUTIONS, BY COMPONENT,  2023 VS. 2028 (USD MILLION) 37
FIGURE 11 ADVANCE CARE PLANNING SOLUTIONS, BY AGE GROUP,  2023 VS. 2028 (USD MILLION) 38
FIGURE 12 ADVANCE CARE PLANNING SOLUTIONS, BY END USER,  2023 VS. 2028 (USD MILLION) 38
FIGURE 13 ADVANCE CARE PLANNING SOLUTIONS MARKET: GEOGRAPHICAL SNAPSHOT 39
4 PREMIUM INSIGHTS 40
4.1 ADVANCE CARE PLANNING SOLUTIONS MARKET OVERVIEW 40
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET GROWTH 40
4.2 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET,  BY END USER AND COUNTRY (2022) 41
FIGURE 15 JAPAN TO DOMINATE ASIA PACIFIC MARKET IN 2022 41
4.3 REGIONAL MIX: ADVANCE CARE PLANNING SOLUTIONS MARKET (2021–2028) 41
FIGURE 16 ASIA TO REGISTER HIGHEST GROWTH RATE OVER 2023–2028 41
4.4 ADVANCE CARE PLANNING SOLUTIONS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES, 2023 VS. 2028 42
FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH OVER STUDY PERIOD 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
FIGURE 18 ADVANCE CARE PLANNING SOLUTIONS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES 43
TABLE 2 MARKET DYNAMICS: ADVANCE CARE PLANNING SOLUTIONS MARKET 44
5.2.1 DRIVERS 44
5.2.1.1 Rising investments in ACP 44
5.2.1.2 Government initiatives and regulations to enhance patient care and autonomy 45
5.2.1.3 Cost-cutting potential of ACP solutions 45
5.2.1.4 Rising geriatric population and chronic disease prevalence 46
5.2.2 OPPORTUNITIES 46
5.2.2.1 Technological advancements and digital solutions 46
5.2.2.2 Policy support and legislative frameworks 47
5.2.2.3 Personalized solutions 47
5.2.3 CHALLENGES 47
5.2.3.1 Fragmented healthcare systems and integration & cultural challenges 47
5.2.3.2 Complexity of healthcare systems 48
5.2.3.3 Lack of interdisciplinary collaboration and communication 48
5.3 INDUSTRY TRENDS 49
5.3.1 DIGITAL TRANSFORMATION OF ACP 49
5.3.2 DATA-DRIVEN INSIGHTS: TRANSFORMING ACP 49
5.3.3 ENHANCING PATIENT ENGAGEMENT AND PERSONALIZED CARE IN ACP 49
5.4 TECHNOLOGY ANALYSIS 50
5.4.1 TECHNOLOGY STACK 50
5.4.1.1 EHRs and digital platforms 50
5.4.1.2 Telemedicine/Telehealth 50
5.4.1.3 Digital access 50
5.4.1.4 Patient decision support 51
5.4.1.5 Blockchain technology 51
5.5 PORTER’S FIVE FORCES ANALYSIS 52
TABLE 3 ADVANCE CARE PLANNING SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS 52
5.5.1 INTENSITY OF COMPETITIVE RIVALRY 52
5.5.2 BARGAINING POWER OF SUPPLIERS 52
5.5.3 BARGAINING POWER OF BUYERS 52
5.5.4 THREAT OF NEW ENTRANTS 53
5.5.5 THREAT OF SUBSTITUTES 53
5.6 REGULATORY LANDSCAPE 53
5.6.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 53
TABLE 4 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 53
TABLE 5 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 54
TABLE 6 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 56
TABLE 7 ADVANCE CARE PLANNING SOLUTIONS MARKET: REGULATORY STANDARDS 57
5.7 VALUE CHAIN ANALYSIS 58
FIGURE 19 ADVANCE CARE PLANNING SOLUTIONS MARKET: VALUE CHAIN ANALYSIS (2022) 58
5.7.1 RESEARCH AND PRODUCT DEVELOPMENT 58
5.7.2 SERVICE DELIVERY AND IMPLEMENTATION 58
5.7.3 END-USER INDUSTRIES AND AFTERSALES SERVICE PROVIDERS 58
5.8 ECOSYSTEM/MARKET MAP 59
FIGURE 20 ADVANCE CARE PLANNING SOLUTIONS MARKET: ECOSYSTEM ANALYSIS 59
5.9 PATENT ANALYSIS 59
FIGURE 21 NUMBER OF PATENTS PUBLISHED, JANUARY 2013 TO JULY 2023 59
FIGURE 22 ADVANCE CARE PLANNING SOLUTIONS: TOP PATENT OWNERS 60
TABLE 8 KEY PATENTS IN ADVANCE CARE PLANNING SOLUTIONS MARKET 60
5.10 ADJACENT MARKET ANALYSIS 61
FIGURE 23 CARE MANAGEMENT SOLUTIONS MARKET: MARKET OVERVIEW 62
FIGURE 24 POPULATION HEALTH MANAGEMENT MARKET: MARKET OVERVIEW 62
5.11 CASE STUDY ANALYSIS 63
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 64
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 64
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 64
TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) 64
5.12.2 BUYING CRITERIA 64
FIGURE 26 KEY BUYING CRITERIA FOR ACP SOLUTION COMPONENTS 64
TABLE 10 KEY BUYING CRITERIA FOR ACP SOLUTION COMPONENTS 65
5.13 KEY CONFERENCES AND EVENTS IN 2023–2024 65
TABLE 11 ADVANCE CARE PLANNING SOLUTIONS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2023–2024 65
5.14 TRENDS/DISRUPTIONS IMPACTING BUYERS 66
FIGURE 27 ADVANCE CARE PLANNING SOLUTIONS: TRENDS/DISRUPTIONS IMPACTING BUYERS 66
6 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT 67
6.1 INTRODUCTION 68
TABLE 12 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 68
6.2 SOFTWARE 68
6.2.1 SOFTWARE TO GROW AT HIGHEST CAGR OVER FORECAST PERIOD 68
TABLE 13 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY,  2021–2028 (USD MILLION) 69
6.3 SERVICES 69
6.3.1 GROWING AWARENESS OF ACP TO DRIVE DEMAND FOR SERVICES 69
TABLE 14 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR SERVICES, BY COUNTRY,  2021–2028 (USD MILLION) 70
7 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP 71
7.1 INTRODUCTION 72
TABLE 15 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 72
7.2 ELDERLY POPULATION 72
7.2.1 RISING CHRONIC DISEASE PREVALENCE IN OLDER ADULTS TO DRIVE MARKET 72
TABLE 16 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR ELDERLY POPULATION,  BY COUNTRY, 2021–2028 (USD MILLION) 73
7.3 MIDDLE-AGED ADULTS 73
7.3.1 GROWING AWARENESS TO BOOST DEMAND FOR ACP 73
TABLE 17 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR MIDDLE-AGED ADULTS,  BY COUNTRY, 2021–2028 (USD MILLION) 74
7.4 YOUNG ADULTS 74
7.4.1 RISING RELEVANCE OF ACP AMONG YOUNG ADULTS TO DRIVE DEMAND 74
TABLE 18 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR YOUNG ADULTS, BY COUNTRY, 2021–2028 (USD MILLION) 75
8 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER 76
8.1 INTRODUCTION 77
TABLE 19 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 77
8.2 B2B 77
8.2.1 B2B SEGMENT TO DOMINATE END-USER MARKET 77
TABLE 20 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 21 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE,  2021–2028 (USD MILLION) 78
TABLE 22 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR HEALTHCARE PROVIDERS,  BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 23 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION) 79
8.3 B2C 80
8.3.1 B2C END USERS TO REGISTER HIGHEST GROWTH OVER FORECAST PERIOD 80
TABLE 24 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 81
TABLE 25 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR BY B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 81
TABLE 26 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR CAREGIVERS, BY COUNTRY,  2021–2028 (USD MILLION) 82
TABLE 27 ADVANCE CARE PLANNING SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY,  2021–2028 (USD MILLION) 82
9 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY REGION 83
9.1 INTRODUCTION 84
TABLE 28 ADVANCE CARE PLANNING SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION) 84
9.2 NORTH AMERICA 84
FIGURE 28 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET SNAPSHOT 85
TABLE 29 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 85
TABLE 30 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 86
TABLE 31 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 86
TABLE 32 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 86
TABLE 33 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 87
TABLE 34 NORTH AMERICA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 87
9.2.1 US 87
9.2.1.1 US to hold largest share of North American market 87
TABLE 35 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 88
TABLE 36 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 88
TABLE 37 US: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 88
TABLE 38 US: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 89
TABLE 39 US: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE,  2021–2028 (USD MILLION) 89
9.2.2 CANADA 89
9.2.2.1 Favorable government initiatives to drive market 89
TABLE 40 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 90
TABLE 41 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 90
TABLE 42 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 90
TABLE 43 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 91
TABLE 44 CANADA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE,  2021–2028 (USD MILLION) 91
9.3 EUROPE 91
TABLE 45 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 92
TABLE 46 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 92
TABLE 47 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 92
TABLE 48 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 93
TABLE 49 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 93
TABLE 50 EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE,  2021–2028 (USD MILLION) 93
9.3.1 GERMANY 94
9.3.1.1 Germany to hold largest share of European market 94
TABLE 51 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 94
TABLE 52 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 94
TABLE 53 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 95
TABLE 54 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS,  BY TYPE, 2021–2028 (USD MILLION) 95
TABLE 55 GERMANY: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS,  BY TYPE, 2021–2028 (USD MILLION) 95
9.3.2 UK 96
9.3.2.1 Rising awareness and emphasis on ACP to support market growth 96
TABLE 56 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 96
TABLE 57 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 96
TABLE 58 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 97
TABLE 59 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 97
TABLE 60 UK: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE,  2021–2028 (USD MILLION) 97
9.3.3 REST OF EUROPE 98
TABLE 61 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 98
TABLE 62 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 99
TABLE 63 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 99
TABLE 64 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 99
TABLE 65 REST OF EUROPE: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 100
9.4 ASIA PACIFIC 100
FIGURE 29 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET SNAPSHOT 101
TABLE 66 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COUNTRY,  2021–2028 (USD MILLION) 102
TABLE 67 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 102
TABLE 68 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 102
TABLE 69 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 103
TABLE 70 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS,  BY TYPE, 2021–2028 (USD MILLION) 103
TABLE 71 ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS,  BY TYPE, 2021–2028 (USD MILLION) 103
9.4.1 JAPAN 104
9.4.1.1 Growing cancer incidence and rising awareness to drive market 104
TABLE 72 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 104
TABLE 73 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 104
TABLE 74 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 105
TABLE 75 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 76 JAPAN: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE,  2021–2028 (USD MILLION) 105
9.4.2 CHINA 106
9.4.2.1 China to register highest CAGR over forecast period 106
TABLE 77 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 106
TABLE 78 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 106
TABLE 79 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 107
TABLE 80 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 107
TABLE 81 CHINA: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE,  2021–2028 (USD MILLION) 107
9.4.3 REST OF ASIA PACIFIC 108
TABLE 82 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION) 108
TABLE 83 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP, 2021–2028 (USD MILLION) 108
TABLE 84 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 109
TABLE 85 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 109
TABLE 86 REST OF ASIA PACIFIC: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 109
9.5 REST OF THE WORLD 110
TABLE 87 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY COMPONENT,  2021–2028 (USD MILLION) 110
TABLE 88 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY AGE GROUP,  2021–2028 (USD MILLION) 110
TABLE 89 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET, BY END USER,  2021–2028 (USD MILLION) 111
TABLE 90 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2B END USERS, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 91 REST OF THE WORLD: ADVANCE CARE PLANNING SOLUTIONS MARKET FOR B2C END USERS, BY TYPE, 2021–2028 (USD MILLION) 111
10 COMPETITIVE LANDSCAPE 112
10.1 INTRODUCTION 112
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 112
FIGURE 30 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS BETWEEN JANUARY 2020 AND AUGUST 2023 113
10.3 MARKET RANKING ANALYSIS 114
FIGURE 31 ADVANCE CARE PLANNING SOLUTIONS MARKET RANKING ANALYSIS,  BY PLAYER, 2022 114
10.4 COMPANY EVALUATION MATRIX, 2022 114
10.4.1 STARS 114
10.4.2 EMERGING LEADERS 114
10.4.3 PERVASIVE PLAYERS 115
10.4.4 PARTICIPANTS 115
FIGURE 32 ADVANCE CARE PLANNING: COMPANY EVALUATION MATRIX (2022) 115
10.5 COMPETITIVE BENCHMARKING 116
TABLE 92 ADVANCE CARE PLANNING SOLUTIONS: COMPANY FOOTPRINT ANALYSIS 116
TABLE 93 COMPONENT FOOTPRINT ANALYSIS (16 COMPANIES) 116
TABLE 94 END-USER FOOTPRINT ANALYSIS (16 COMPANIES) 117
10.6 KEY PLAYER ANALYSIS 118
10.7 COMPETITIVE SCENARIO AND TRENDS 119
10.7.1 PRODUCT/SERVICE LAUNCHES & APPROVALS 119
TABLE 95 PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020–AUGUST 2023 119
10.7.2 DEALS 119
TABLE 96 DEALS, JANUARY 2020–AUGUST 2023 119
10.7.3 OTHER DEVELOPMENTS 120
TABLE 97 OTHER DEVELOPMENTS, JANUARY 2020– AUGUST 2023 120
11 COMPANY PROFILES 121
11.1 KEY PLAYERS 121
(Company overview, Products & Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices, and Weaknesses and competitive threats)*
11.1.1 ADVAULT, INC. 121
TABLE 98 ADVAULT, INC.: BUSINESS OVERVIEW 121
11.1.2 VYNCACARE 124
TABLE 99 VYNCACARE: BUSINESS OVERVIEW 124
11.1.3 WISERCARE, INC. 126
TABLE 100 WISERCARE, INC.: BUSINESS OVERVIEW 126
11.1.4 IRIS 128
TABLE 101 IRIS: BUSINESS OVERVIEW 128
11.1.5 KODA HEALTH 130
TABLE 102 KODA HEALTH: BUSINESS OVERVIEW 130
11.1.6 THOROUGHCARE, INC. 131
TABLE 103 THOROUGHCARE, INC.: BUSINESS OVERVIEW 131
11.1.7 VITAL DECISIONS LLC 132
TABLE 104 VITAL DECISIONS LLC: BUSINESS OVERVIEW 132
11.1.8 AFFIRM HEALTH, INC. 133
TABLE 105 AFFIRM HEALTH, INC.: BUSINESS OVERVIEW 133
11.1.9 MIDEO 134
TABLE 106 MIDEO: BUSINESS OVERVIEW 134
11.1.10 NEW CENTURY HEALTH 135
TABLE 107 NEW CENTURY HEALTH: BUSINESS OVERVIEW 135
11.1.11 THANACARE 136
TABLE 108 THANACARE: BUSINESS OVERVIEW 136
11.1.12 HONOR MY DECISIONS LLC 137
TABLE 109 HONOR MY DECISIONS: BUSINESS OVERVIEW 137
11.2 NON-PROFIT ORGANIZATIONS 138
11.2.1 SHARP HEALTHCARE 138
TABLE 110 SHARP HEALTHCARE: BUSINESS OVERVIEW 138
11.2.2 ACP DECISIONS 139
TABLE 111 ACP DECISIONS: BUSINESS OVERVIEW 139
11.2.3 BRONSON HEALTHCARE 140
TABLE 112 BRONSON HEALTHCARE: BUSINESS OVERVIEW 140
11.2.4 ISLAND HEALTH 141
TABLE 113 ISLAND HEALTH: BUSINESS OVERVIEW 141
11.2.5 MUNSON HEALTHCARE 142
TABLE 114 MUNSON HEALTHCARE: BUSINESS OVERVIEW 142
*Details on Company overview, Products & Services offered, Recent developments, MnM view, Key strengths/Right to win, Strategic choices, and Weaknesses and competitive threats might not be captured in case of unlisted companies.
12 APPENDIX 143
12.1 DISCUSSION GUIDE 143
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL 146
12.3 CUSTOMIZATION OPTIONS 148
12.4 RELATED REPORTS 148
12.5 AUTHOR DETAILS 149